side effects of glp 1 drugs for weight loss GI Adverse Glucagon-Like Peptide-1 Receptor Agonists GLP-1 medication side effects for

These statements reflect company marketing language and have not been independently verified as evidence of weight-loss or GLP-1 effects

doi: 10.1002/cld.1027

Mazdutide and other dual agonists in development further expand the options

Research indicates that the medication promotes systemic fat reduction rather than directly affecting facial fat cells, which results in a gaunt facial appearance and signs of premature aging [55]

Another goal of the study was weight loss, and the drug succeeded there, too: Participants on semaglutide lost about 13% of their body weight, compared with 2.6% for those on placebo, over the course of the year-long trial